IMR Press / FBL / Volume 1 / Issue 4 / DOI: 10.2741/A123

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article
Adhesion molecules in human sperm-oocyte interaction: relevance to infertility
Show Less
1 Section of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190, USA
Academic Editor:Rajesh K. Naz
Front. Biosci. (Landmark Ed) 1996, 1(4), 161–176; https://doi.org/10.2741/A123
Published: 1 August 1996
(This article belongs to the Special Issue Male reproductive medicine)
Abstract

Fertilization involves cell-cell fusion of a sperm with the oocyte. This fusion restores the diploid genome, activates the oocyte, and initiates embryonic development. The identification of proteins mediating the fusion of sperm with oocyte plasma membrane (oolemma) is important to a deeper knowledge of fertilization. Defects in sperm-oocyte fusion may account for some form of human infertility. The hypothesis that sperm plasma membrane and oolemma carry complementary molecules involved in multistep fusion process has been validated by studies of cell adhesion molecules (integrins) in sperm-oocyte interaction in a number of animal models and human in vitro fertilization assays. Integrins or integrin-like molecules and complement proteins present on the surface of mammalian gametes, might be involved in the interaction between oocyte and sperm at fertilization. This review will provide an overview of the interaction of human sperm membrane with the oolemma, the nature of cell adhesion molecules, their expression profiles and their possible involvement in adhesive and fusogenic events in human fertilization. Unraveling the unique molecules involved in human sperm plasma membrane-oolemma fusion will be an important component for the development of a new set of contraceptive vaccines.

Share
Back to top